250 related articles for article (PubMed ID: 25833766)
1. Genomic instability in the PARK2 locus is associated with Parkinson's disease.
Ambroziak W; Koziorowski D; Duszyc K; Górka-Skoczylas P; Potulska-Chromik A; Sławek J; Hoffman-Zacharska D
J Appl Genet; 2015 Nov; 56(4):451-461. PubMed ID: 25833766
[TBL] [Abstract][Full Text] [Related]
2. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
Semenova EV; Shadrina MI; Slominsky PA; Ivanova-Smolenskaya IA; Bagyeva G; Illarioshkin SN; Limborska SA
Mov Disord; 2012 Jan; 27(1):139-42. PubMed ID: 21915905
[TBL] [Abstract][Full Text] [Related]
3. Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.
Elfferich P; Verleun-Mooijman MC; Maat-Kievit JA; van de Warrenburg BP; Abdo WF; Eshuis SA; Leenders KL; Hovestadt A; Zijlmans JC; Stroy JP; van Swieten JC; Boon AJ; van Engelen K; Verschuuren-Bemelmans CC; Lesnik-Oberstein SA; Tassorelli C; Lopiano L; Bonifati V; Dooijes D; van Minkelen R
Neurogenetics; 2011 Nov; 12(4):263-71. PubMed ID: 21993715
[TBL] [Abstract][Full Text] [Related]
4. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
[TBL] [Abstract][Full Text] [Related]
5. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
[TBL] [Abstract][Full Text] [Related]
6. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
van der Merwe C; Carr J; Glanzmann B; Bardien S
Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088
[TBL] [Abstract][Full Text] [Related]
7. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Szirkowiec W; Janik P; Bal J; Friedman A
Parkinsonism Relat Disord; 2010 Feb; 16(2):136-8. PubMed ID: 19628420
[TBL] [Abstract][Full Text] [Related]
9. Novel compound heterozygous mutations in the
Shi Y; Kawakami H; Zang W; Li G; Zhang J; Xu C
Brain Behav; 2018 Jan; 8(1):e00901. PubMed ID: 29568695
[TBL] [Abstract][Full Text] [Related]
10. Microhomology-mediated mechanisms underlie non-recurrent disease-causing microdeletions of the FOXL2 gene or its regulatory domain.
Verdin H; D'haene B; Beysen D; Novikova Y; Menten B; Sante T; Lapunzina P; Nevado J; Carvalho CM; Lupski JR; De Baere E
PLoS Genet; 2013; 9(3):e1003358. PubMed ID: 23516377
[TBL] [Abstract][Full Text] [Related]
11. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
[TBL] [Abstract][Full Text] [Related]
12. A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson's disease.
Cazeneuve C; Sân C; Ibrahim SA; Mukhtar MM; Kheir MM; Leguern E; Brice A; Salih MA
Neurogenetics; 2009 Jul; 10(3):265-70. PubMed ID: 19214605
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
[TBL] [Abstract][Full Text] [Related]
14. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.
Shadrina MI; Semenova EV; Slominsky PA; Bagyeva GH; Illarioshkin SN; Ivanova-Smolenskaia II; Limborska SA
BMC Med Genet; 2007 Feb; 8():6. PubMed ID: 17324265
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines.
Mitsui J; Takahashi Y; Goto J; Tomiyama H; Ishikawa S; Yoshino H; Minami N; Smith DI; Lesage S; Aburatani H; Nishino I; Brice A; Hattori N; Tsuji S
Am J Hum Genet; 2010 Jul; 87(1):75-89. PubMed ID: 20598272
[TBL] [Abstract][Full Text] [Related]
16. Decoding NF1 Intragenic Copy-Number Variations.
Hsiao MC; Piotrowski A; Callens T; Fu C; Wimmer K; Claes KB; Messiaen L
Am J Hum Genet; 2015 Aug; 97(2):238-49. PubMed ID: 26189818
[TBL] [Abstract][Full Text] [Related]
17. Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.
Kim SY; Seong MW; Jeon BS; Kim SY; Ko HS; Kim JY; Park SS
Clin Genet; 2012 Jul; 82(1):77-82. PubMed ID: 21534944
[TBL] [Abstract][Full Text] [Related]
18. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders.
Lee JA; Carvalho CM; Lupski JR
Cell; 2007 Dec; 131(7):1235-47. PubMed ID: 18160035
[TBL] [Abstract][Full Text] [Related]
19. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
[TBL] [Abstract][Full Text] [Related]
20. Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer.
Denison SR; Callahan G; Becker NA; Phillips LA; Smith DI
Genes Chromosomes Cancer; 2003 Sep; 38(1):40-52. PubMed ID: 12874785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
